drugset / Trial / NCT05337228

Clinical Trial to Evaluate the Safety and Efficacy of IN-C006 Peri Inj. Compared With RPN301

NCT05337228 ↗

Phase 3 Completed 59 enrolled HK inno.N Corporation
RandomizedParallel-groupOpen-labelSupportive care

Summary

This study is designed to evaluate the safety and efficacy of IN-C006 Peri inj. and RPN301 in postoperative patients requiring central parenteral nutrition.

Timeline

Start
2022-08-09
Primary completion
2023-02-10
Completion
2023-02-24

Drugs

EvaluationDrugModalityDoseRoute
Subject IN-C006 Peri inj. Unknown 1904 ml Other
Comparator RPN301 Unknown 2020 ml Other